1 – 10 of 21
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1) : final survival analysis of a randomised, controlled, phase 3 trial
(
- Contribution to journal › Article
- 2021
-
Mark
The impact of PRODIGE 7 on the current worldwide practice of CRS-HIPEC for colorectal peritoneal metastases : A web-based survey and 2021 statement by Peritoneal Surface Oncology Group International (PSOGI)
(
- Contribution to journal › Article
- 2019
-
Mark
Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases : A multi-institutional experience
(
- Contribution to journal › Article
-
Mark
Cost Effectiveness of Interval Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer on the Basis of a Randomized Phase III Trial
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Cost effectiveness of interval cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in stage III ovarian cancer on the basis of a randomized phase III trial
(
- Contribution to journal › Article
-
Mark
Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC) : a multicentre, open-label, randomised trial
(
- Contribution to journal › Article
- 2018
-
Mark
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
(
- Contribution to journal › Article
- 2017
-
Mark
Registries on peritoneal surface malignancies throughout the world, their use and their options
(
- Contribution to journal › Article
-
Mark
Survival of patients with colorectal peritoneal metastases is affected by treatment disparities among hospitals of diagnosis : A nationwide population-based study
(
- Contribution to journal › Article
- 2016
-
Mark
Short-term outcome in patients treated with cytoreduction and HIPEC compared to conventional colon cancer surgery
(
- Contribution to journal › Article